Welcoming Remarks

ISAO KANO, President & CEO, JCIE/Japan 

YASUHISA SHIOZAKI, former Minister of Health, Labour and Welfare, Japan; Chair, GHMD Advisory Committee

Session 1: Accelerate R&D of medical countermeasures (including antibiotics) with equity embedded by design

Moderator: HEULWEN PHILPOT, Head of Secretariat, IPPS 

THOMAS CUENI, Director General, International Federation of Pharmaceutical Manufacturers & Association (IFPMA)

YASUHIRO FUJIWARA, Chief Executive Officer, Pharmaceuticals and Medical Devices Agency (PMDA), Japan; Chair, Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia; Member, GHMD Advisory Committee

RICHARD HATCHETT, CEO, CEPI [introductory remarks]

LYNETTE MABOTE-EYDE, Access to Diagnostics/ Medicines Researcher & Global Health Advocate, Sub-Saharan African Programme on Access to Medicines and Diagnostic (SAPAM), South Africa

BILL RODRIGUEZ, CEO, FIND

RINI MULIA SARI, Vice President of Surveillance and Clinical Research, Bio Farma Company, Indonesia

BEATRIZ DE CASTRO FIALHO, Senior Scientific Advisor, Immunobiological Technology Institute and Coordinator of Vaccine Committee, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Brazil [online]

Session 2: Ensure more equitable access to MCMs (including antibiotics) through ongoing efforts to build resilient health systems

Moderator: DIAH SATYANI SAMINARSIH, Founder and CEO, Center for Indonesia’s Strategic Development Initiatives (CISDI); Member, GHMD Advisory Committee

Summary of Themes: BENJAMIN SCHREIBER, Senior Advisor, Health Strategy and Management, UNICEF [online]

YANN FERRISSE, Director, Business Development & Partner Engagement, Global Antibiotic R&D Partnership (GARDP)

BERNARD HAUFIKU, Council Chair & Founder, Africa Public Health Foundation

PETRA KHOURY, Health and Care Director, International Federation of Red Cross and Red Crescent Societies (IFRC)

JEROME KIM, Director General, International Vaccine Institute (IVI)

DIANNE STEWART, Deputy Director of External Relations and Communications Division, and Head of Donor Relations Department, The Global Fund to Fight AIDS, Tuberculosis and Malaria

IKUO TAKIZAWA, Senior Deputy Director-General and Senior Director, Office for COVID-19 Response, Human Development Department, JICA

Luncheon Dialogue: Stories from the Field

Moderator: JOANNE LIU, Professor, School of Population & Global Health, McGill University; Director, Pandemics and Health Emergencies Readiness Lab (PERL); Member, GHMD Advisory Committee

KHUAT THI HAI OANH, Executive Director, Center for Supporting Community Development Initiatives, Vietnam

NGUISSALI TURPIN, Executive Director, ENDA Santé; Member, GHMD Advisory Committee

Session 3: Workforce and data—essential elements to mitigate impact of future pandemics

Moderator: ILONA KICKBUSCH, Founder, Global Health Centre at Graduate Institute of International & Development Studies in Geneva; Member, GHMD Advisory Committee 

Summary of Themes: VALERIE NKAMGANG BEMO, Deputy Director, Emergency Response, Health, Bill & Melinda Gates Foundation

FERDINAL FERNANDO, Assistant Director & Head of Health Division, ASEAN Secretariat

ANA LIZA HOMBRADO DURAN, Director, Research Institute of Tropical Medicine (RITM), Philippines

SADAF LYNES, Director of Collaborative Surveillance, Workforce and Health Emergencies, the International Association of National Public Health Institutes (IANPHI)

PATRICK NGUKU, Regional Coordinator, Anglophone West Africa, African Field Epidemiology Network (AFENET)

SCOTT PENDERGAST, Director of the Strategic Planning, and Partnerships for the Health Emergencies Programme, WHO [online]

Session 4: Global and regional mechanisms of financing and knowledge sharing to support country-led efforts for PPR and resilient health systems

Moderator and Summary of Themes: CAROLYN REYNOLDS, Co-Founder, PAN

PRIYA BASU, Executive Head, Pandemic Fund [online]

MASAKI INABA, Chair, Japan CSO Network on Global Health; Domestic Coordinator, C7 2023 Global Health Working Group

JADEJ THEMMATACHAREE, Secretary General, National Health Security Office (NHSO), Thailand

JUSTIN KOONIN, Co-chair, Steering Committee, UHC2030 [online]

MAGNUS LINDELOW, Practice Manager for Health, Nutrition and Population for Eastern and Southern Africa, the World Bank [online]

MERCY MWANGANGI, Steering Group Co-Chair, Future of Global Health Initiatives; Former Chief Administrative Secretary, Ministry of Health, Kenya [online]

Session 5: Remaining challenges for G7 2024 and roles of multistakeholder partnerships

Moderator: OSAMU KUNII, CEO and Executive Director, GHIT Fund; Deputy Chair, GHMD Advisory Committee

STEFANIA BURBO, Focal Point and Advocacy Officer, Global Health Italian Network; International Coordinator, C7 2023 Global Health Working Group; GHMD Advisory Committee Member [online]

JEREMY FARRAR, WHO Chief Scientist [online]

LISA HEINRICH, European Government Relations Lead, Wellcome Trust

GUIDO RASI, Professor of Microbiology, Tor Vergata University of Rome; Advisor to the Minister of Health, Italy; GHMD Advisory Committee Member

RENU SWARUP, Former Secretary, Department of Biotechnology, Ministry of Science & Technology; GHMD Advisory Committee Member [online]

Closing Session

SERGIO IAVICOLI, Director General of the Directorate for communication and European and international relations, Italian Ministry of Health [online]

RICHARD HATCHET

World AIDS Day Special Reception

KEIZO TAKEMI, Minister of Health, Labour and Welfare (MHLW), Japan

RICHARD HATCHET

Keynote Speech: Lessons from HIV/AIDS and COVID-19 Responses—Realizing equitable access to innovation for global health: SALIM ABDOOL KARIM, Director, Centre for the AIDS Programme of Research in South Africa (CAPRISA)

FATIMA ABBA, Senior Programme Officer, Pandemic Preparedness & Response, Bill and Melinda Gates Foundation

SALIM S. ABDOOL KARIM, Director, CAPRISA

QUARRAISHA ABDOOL KARIM Associate Scientific Director, CAPRISA

SARAH K. ABE, Section Head, National Cancer Center Japan

AYUSHI AGNIHOTRI, Deputy Director, Resource Mobilization, FIND

MARIKO AOKI, Policy Specialist, HIV, Health & Development Group, Bureau for Policy & Programme Support, United Nations Development Programme (UNDP)

TSUNENORI AOKI. Professor, Office for Global Relations, School of Tropical Medicine and Global Health, Nagasaki University

YUSUKE ARIYOSHI. Director, Healthcare Policy, Government Affairs Dept., Shionogi & Co., Ltd.; Lead, Infectious Disease Group, Global Health Working Group, Japan Pharmaceutical Manufacturer’s Association (JPMA)

VICTOR BAMPOE. Head, Partnerships for Programme Implementation, The Joint United Nations Programme on HIV/AIDS (UNAIDS)

PRIYA BASU, Executive Head, Pandemic Fund [online]

VALERIE NKAMGANG BEMO, Deputy Director, Emergency Response, Health, Bill & Melinda Gates Foundation

NINA BLACK, Advisor, Global Government Relations, Wellcome Trust

SEFANIA BURBO, Focal Point and Advocacy Officer, Global Health Italian Network; International Coordinator, C7 2023 Global Health Working Group [online]

SADHAVI CHAUHAN, Government Engagement and Policy Manager, Access to Medicine Foundation

NATSUMI CHIBA, Global Health Strategy Division, Ministry of Foreign Affairs, Japan

BEATRICE COATES, Policy Officer, International Pandemic Preparedness Secretariat (IPPS)

THOMAS B. CUENI, Director General, The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

MANDEEP DHALIWAL, Director, HIV & Health Group, United Nations Development Programme (UNDP)

ERIN DUFFY, Chief of R&D, CARB-X

TIM ENDY, Program Leader, Coalition for Epidemic Preparedness Innovations (CEPI)

SATOSHI EZOE, Director, Global Health Strategy Division, Ministry of Foreign Affairs, Japan

JEREMY FARRAR, Chief Scientist, World Health Organization (WHO) [online]

PHILIPPE J. FAUCHET, Founder, Mirasense Partners

MARK FEINBERG, President and CEO, International AIDS Vaccine Initiative (IAVI)

DAMIANO DE FELICE, Director of Development and External Engagement, CARB-X [online]

FERDINAL M. FERNANDO, Assistant Director and Head of Health Division, ASEAN Secretariat

YANN FERRISSE, Director, Business Development & Partner Engagement, Global Antibiotic R&D Partnership (GARDP)

BEATRIZ DE CASTRO FIALHO, Senior Scientific Advisor, Immunobiological Technology Institute and Coordinator of Vaccine Committee, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Brazil

YASUHIRO FUJIWARA, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)

KUNIHIRO FUNAKOSHI, Advisor, Sysmex Corporation

CHARLES GORE, Executive Director, Medicines Patent Pool (MPP)

RICHARD HATCHETT, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)

BERNARD HAUFIKU, Council Chair & Founder, Africa Public Health Foundation

LISA HEINRICH, European Government Relations Lead, Wellcome Trust

HARUHIKO HIRATE, Executive Vice President & Chief Corporate Affairs Officer, Dentsu Group Inc. [online]

SALLY GIRGIS HJOBERG, Head of Investor Relations, Coalition for Epidemic Preparedness Innovations (CEPI)

ANA LIZA HOMBRADO DURAN, Director, Research Institute of Tropical Medicine (RITM), Philippines

YUMIKO HORIE, Director of Policy, Advocacy and Campaigns, Save the Children Japan

SERGIO IAVICOLI, Director General, Directorate for Communication and European and International Relations, Ministry of Health, Italy [online]

ANNA IELE, Agricultural and food Attaché, Italian Embassy in Tokyo

NAOKO IIZUKA, Japan Liason Executive, IFPMA

MASAYUKI IMAGAWA, Chief Executive, General Incorporated Association, Japan Association of Vaccine Industries

MASAKI INABA, Chair, Japan CSO Network on Global Health; Domestic Coordinator, C7 2023 Global Health Working Group

EMI INAOKA, Senior Advisor, Health Finance, The Global Fund to Fight AIDS, Tuberculosis and Malaria

HAJIME INOUE, Advisor, Health, Nutrition and Population, World Bank [online]

KEN ISHII, Professor, Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo

AKIKO ITO, Japan International Cooperation Agency (JICA)

NAOKI ITO, Ambassador for Global Health, Executive Director for Healthcare Policy, Cabinet Office, Government of Japan

SATOKO ITOH, Managing Director, Japan Center for International Exchange (JCIE)

JADEJ THAMMATACHAREE, Secretary General, National Health Security Office (NHSO), Thailand

KAZUAKI JINDAI, Assistant Professor, Graduate School of Medicine, Tohoku University; Meiseikai-Kinshicho Clinic; Allm.inc.

KANCHANA SRICHOMPHU, Director of Budgeting and Planning Department, National Health Security Office (NHSO), Thailand

ISAO KANO, President & CEO, Japan Center for International Exchange (JCIE)

MIHOKO KASHIWAKURA, Head of East Asia Relations, Global Policy and Advocacy, Bill & Melinda Gates Foundation

KAZUYO KATO, Executive Director, Japan Center for International Exchange (JCIE/USA)

KAORI KAWARABAYASHI, Technical Support Mechanism Manager, the Joint United Nations Programme on HIV/AIDS (UNAIDS)

PETRA KHOURY, Director, Health & Care Department, International Federation of Red Cross and Red Crescent Societies

ILONA KICKBUSCH, Founder, Global Health Centre, Graduate Institute of International & Development Studies in Geneva

JEROME KIM, Director General, International Vaccine Institute

KIYOSHI KITA, Dean, School of Tropical Medicine and Global Health, Nagasaki University

KIYOSHI KODERA, Board member, WaterAid Japan

DAISUKE KOGA, Director, Office of International Regulatory Affairs, Ministry of Health, Labour and Welfare (MHLW)

NORIHIRO KOKUDO, President, National Center for Global Health and Medicine (NCGM) [online]

JUSTIN KOONIN, Co-Chair, Steering Committee, UHC2030 [online]

ARISA KOYAMA, Program Officer, Bill & Melinda Gates Foundation

OSAMU KUNII, CEO, Global Health Innovative Technology Fund (GHIT Fund)

KIYOSHI KUROKAWA, Professor Emeritus, National Graduate Institute for Policy Studies, Japan

ADELINE LASSAUX, Science and Technology Attaché, Health, Environment, and Life Division, Service for Science and Technologies, Embassy of France in Japan

CHIA-SAN SUSAN LIN, Senior Analyst, Public Health Advisor, PATH

MAGNUS LINDELOW, Practice Manager for Health, Nutrition and Population for Eastern and Southern Africa, World Bank [online]

JOANNE LIU, Professor at the School of Population and Global Health, McGill University

SADAF LYNES, Director of Collaborative Surveillance, Workforce and Health Emergencies, International Association of National Public Health Institutes (IANPHI)

LYNETTE MABOTE-EYDE, African-focused IP and Regulatory Consultant, Sub-Saharan African Programme on Access to Medicines and Diagnostic (SAPAM)

SAEDA MAKIMOTO, Principal Research Fellow, JICA Ogata Research Institute

JENNI MAPLE, Associate Director, Advocacy, International AIDS Vaccine Initiative (IAVI)

YOSHIRO MATSUO, Executive Deputy President and Representative Director, Otsuka Pharmaceutical Co., Ltd. [online]

KAZUHARU MATSUOKA, Director, Japan Pharmaceutical Manufacturers Association (JPMA)

MERCY MWANGANGI, Steering Group Co-Chair, Future of Global Health Initiatives; Former Chief Administrative Secretary, Ministry of Health, Kenya [online]

KAORI NAKATANI, Japan Director, the Drugs for Neglected Diseases initiative (DNDi)

PATRICK NGUKU, Regional Coordinator, African Field Epidemiology Network (AFENET)

SANDRA NOBRE, Head of Business Development, Medicines Patent Pool (MPP)

SHUHEI NOMURA, Associate Professor of Health Policy and Management, Keio University

KHUAT THI HAI OANH, Executive Director, Center for Supporting Community Development Initiatives (SCDI)

YOSHIKO OKAMOTO, Deputy Director, Office of Healthcare Policy, Cabinet Secretariat, Government of Japan

SHIGERU OMI, Chairman, Board of Directors, Japan Anti-Tuberculosis Association (JATA) [online]

JASON PEAT, Team Lead, Community Health, Health and Care Department, International Federation of Red Cross and Red Crescent Societies (IFRC)

SCOTT PENDERGAST, Director of the Strategic Planning and Partnerships for the Health Emergencies Programme, World Health Organization (WHO) [online]

HEULWEN PHILPOT, Head of International Pandemic Preparedness Secretariat (IPPS)

FIFA A. RAHMAN, Principal Consultant, Matahari Global Solutions

GUIDO RASI, Professor of Microbiology, Tor Vergata University of Rome; Advisor to the Minister of Health, Italy

CAROLYN REYNOLDS, Founder, Pandemic Action Network (PAN)

BILL RODRIGUEZ, CEO, FIND

EMINA RYE-FLORENTZ, Executive Director, Fund for the Global Fund

DIAH SAMINARIH SAMINARSIH, CEO & Founder, Center for Indonesia’s Strategic Development Initiatives (CISDI)

RINI MULIA SARI, Vice President of Global Clinical Trial, Bio Farma

JUN SASAKI, Partner’s Engagement Lead, Global Antibiotic R&D Partnership (GARDP)

MIDORI SATO, Senior Health Partnership Specialist, United Nations Children’s Fund (UNICEF) Tokyo Office

TAKANORI SATO, Director, Global Public Affairs, Takeda Pharmaceutical Company Ltd.

BENJAMIN SCHREIBER, Senior Advisor, Health Strategy and Management, United Nations Children’s Fund (UNICEF) [online]

YASUHISA SHIOZAKI, Chair, Advisory Committee for the Global Health Multistakeholder Dialogue; former Minister of Health, Labour and Welfare, Japan

HIDEAKI SHIROYAMA, Professor of Public Administration, Graduate School for Law and Politics, and the Graduate School of Public Policy, The University of Tokyo

TOMOFUMI SONE, President, National Institute of Public Health, Japan

DIANNE STEWART, Deputy Director, External Relations and Communications Division; Head, Donor Relations Department, The Global Fund to Fight AIDS, Tuberculosis and Malaria

TOMOKO SUZUKI, Chief Program Officer, Japan Center for International Exchange (JCIE)

RENU SWARUP, Former Secretary, Department of Biotechnology, Ministry of Science &Technology, India [online]

MASAO TAKAHASHI, Head, New Investors, Private Sector Partnerships & Innovation, Gavi, the Vaccine Alliance (Gavi)

SHUNJI TAKAKURA, Director General, Bureau of International Health Cooperation, National Center for Global Health and Medicine (NCGM) [online]

MAKIKO TAKAYAMA, Donor Relations Specialist, The Global Fund to Fight AIDS, Tuberculosis and Malaria

YUI TAKISHIMA, Consultant, Bill & Melinda Gates Foundation

IKUO TAKIZAWA, Senior Deputy Director-General and Senior Director, Office for COVID-19 Response, Human Development Department, JICA

ISAO TESHIROGI, Chief Executive Officer, Shionogi & Co., Ltd.

TAKUYA TONE, International Affairs Department, Japan Pharmaceutical Manufacturers Association [online]

TAKESHI TSUGE, Associate Director, Corporate Communications Department, Corporate Strategy Division, Shionogi & Co., Ltd.

NGUISSALI TURPIN, Executive Director, ENDA Sante

FUYO UENO, Administrative Assistant, United Nations Population Fund (UNFPA) Tokyo Office

SHIORI UI, Board Member, SHARE

AISHAT BUKOLA USMAN, Technical Advisor on Cross-border Surveillance, ECOWAS Regional Center for Surveillance and Disease Control, West African Health Organization (WAHO)

AKIHITO WATABE, Health Specialist, Human and Social Development Office, Sectors Group, Asian Development Bank [online]

KEIKO WATANABE, Consultant, International AIDS Vaccine Initiative (IAVI)

NAOKO YAMAMOTO, Professor, Director of Global Medical Cooperation Center, International University of Health and Welfare